CRC
NEO icon

Curi RMB Capital’s NeoGenomics NEO Stock Holding History

Curi RMB Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
86,132
+809
+0.9% +$7.81K 0.02% 414
2026
Q1 		$633K Buy
85,323
+1,977
+2% +$20.8K 0.01% 540
2025
Q4 		$980K Hold
83,346
– – 0.02% 465
2025
Q3 		$643K Buy
83,346
+86
+0.1% +$602 0.01% 475
2025
Q2 		$609K Buy
+83,260
New +$672K 0.01% 483
2022
Q2 		– Sell
-305,805
Closed -$3.72M – 486
2022
Q1 		$3.72M Buy
305,805
+54,661
+22% +$1.15M 0.12% 152
2021
Q4 		$8.57M Buy
251,144
+7,605
+3% +$298K 0.26% 97
2021
Q3 		$11.7M Buy
243,539
+3,737
+2% +$173K 0.39% 80
2021
Q2 		$10.8M Buy
239,802
+47,497
+25% +$2.1M 0.36% 81
2021
Q1 		$9.28M Buy
192,305
+11,805
+7% +$615K 0.34% 86
2020
Q4 		$9.72M Buy
180,500
+4,005
+2% +$181K 0.36% 76
2020
Q3 		$6.51M Sell
176,495
-5,078
-3% -$189K 0.28% 85
2020
Q2 		$5.63M Buy
181,573
+25,955
+17% +$719K 0.25% 99
2020
Q1 		$4.3M Buy
155,618
+26,249
+20% +$786K 0.2% 117
2019
Q4 		$3.78M Sell
129,369
-9,809
-7% -$234K 0.11% 190
2019
Q3 		$2.66M Buy
139,178
+7,954
+6% +$187K 0.07% 258
2019
Q2 		$2.88M Sell
131,224
-47,152
-26% -$1.03M 0.07% 260
2019
Q1 		$3.65M Buy
178,376
+11,166
+7% +$194K 0.09% 234
2018
Q4 		$2.11M Sell
167,210
-17,436
-9% -$260K 0.05% 330
2018
Q3 		$2.83M Sell
184,646
-46,980
-20% -$649K 0.07% 309
2018
Q2 		$3.04M Sell
231,626
-576,680
-71% -$6.35M 0.07% 287
2018
Q1 		$6.6M Buy
808,306
+269,414
+50% +$2.18M 0.17% 167
2017
Q4 		$4.78M Sell
538,892
-106,365
-16% -$981K 0.12% 231
2017
Q3 		$7.18M Sell
645,257
-332,707
-34% -$3.24M 0.19% 169
2017
Q2 		$8.76M Sell
977,964
-715,352
-42% -$5.68M 0.25% 126
2017
Q1 		$13.4M Sell
1,693,316
-139,000
-8% -$1.13M 0.55% 53
2016
Q4 		$15.7M Sell
1,832,316
-66,600
-4% -$571K 0.84% 30
2016
Q3 		$15.6M Sell
1,898,916
-153,900
-7% -$1.29M 0.85% 28
2016
Q2 		$16.5M Sell
2,052,816
-705,675
-26% -$5.66M 0.86% 24
2016
Q1 		$18.6M Sell
2,758,491
-32,500
-1% -$214K 1.21% 19
2015
Q4 		$22M Sell
2,790,991
-826,423
-23% -$6.05M 1.01% 8
2015
Q3 		$20.7M Sell
3,617,414
-591,200
-14% -$3.66M 1.38% 8
2015
Q2 		$22.8M Hold
4,208,614
– – 1.48% 9
2015
Q1 		$19.7M Buy
4,208,614
+31,561
+0.8% +$137K 1.18% 17
2014
Q4 		$17.4M Buy
4,177,053
+135,043
+3% +$621K 1.06% 22
2014
Q3 		$21.1M Hold
4,042,010
– – 1.29% 15
2014
Q2 		$13.4M Hold
4,042,010
– – 0.85% 31
2014
Q1 		$14M Buy
4,042,010
+146,033
+4% +$547K 0.97% 27
2013
Q4 		$14.1M Buy
3,895,977
+17,590
+0.5% +$61.1K 0.98% 34
2013
Q3 		$11.6M Buy
3,878,387
+181,754
+5% +$512K 0.84% 39
2013
Q2 		$14.7M Buy
+3,696,633
New +$14.1M 1.11% 27

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Curi RMB Capital's NEO Position: Q2 2026 in Review

Curi RMB Capital increased its NeoGenomics (NEO) stake by 0.95% in Q2 2026, buying an estimated $7.81K and bringing the position to 86,132 shares worth $1.26M. The position accounts for 0.02% of the portfolio, ranked #414.

Curi RMB Capital first reported a position in NEO in Q2 2013 and has held it in 41 quarters since. The position peaked at $22.8M in Q2 2015. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Curi RMB Capital held 86,132 shares of NeoGenomics worth $1.26M as of Q2 2026.
  • Curi RMB Capital bought 809 NeoGenomics shares in Q2 2026, an estimated $7.81K.
  • NeoGenomics made up 0.02% of Curi RMB Capital's portfolio in Q2 2026, its #414 holding.
  • Curi RMB Capital first reported a position in NeoGenomics in Q2 2013 and has held it in 41 quarters since.
  • Curi RMB Capital's NeoGenomics position peaked at $22.8M in Q2 2015.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.